About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

For Caregivers – Common Signs of Impending Cancer Death

Advanced Prostate cancer will eventually lead to our death. This is a sad truth that I know we all are very aware. In a study published Monday online in Cancer, researchers identify “eight specific physical signs” indicating a patient “with advanced cancer is entering the last days of life.” The signs that were identified were [...]

*Provenge to Survive Dendreon’s Bankruptcy – Welcome Valeant to the Prostate Cancer Community

Dendreon, the manufacture of the only FDA approved immunologic therapy for prostate cancer had been burdened with significant debt. The debt came from their R&D of Provenge, their seeking FDA approval and the construction of three manufacturing plants to produce the treatment. Sadly, the company was unable to get its income ahead of its debt [...]

*After the Failure of Docetaxel Is There A Best Sequence For Other Treatments?: Results of an Italian Multicenter Study

As we all know there are now a number of new drugs available to treat castrate resistant metastatic prostate cancer (mCRPC). The availability of these new drugs (abiraterone acetate aka Zytiga, cabazitaxel aka Jevtana, and enzalutamide aka Xtandi) for use in men with mCRPC after the failure of chemotherapy (with docetaxel) has opened a number [...]

Understanding the Complexities of Bone Metastases in Prostate Cancer

Our bones operate in a balanced and dynamic system, which in the normal situation keep them strong. Bones are constantly being eliminated and then remade to keep them healthy and read to support our frame. This normal process involves two major kinds of bone cells that work together, in balance, to keep bones healthy and [...]

Obama Says “Men, You Don’t Count” As He Eliminates All Prostate Cancer Funding From His Proposed 2016 Budget At The CDC

Men, you don’t count! You have NO VALUE! That is the absolute truth according to President Obama. Just released budget documents from the President proposed budget for 2016 recommends that ALL CDC funding for Prostate Cancer be eliminated! Let me make this clear, no, the President is not recommending that Prostate Cancer funds be cut, [...]

By |2021-02-17T10:29:53-05:00February 5th, 2015|Advanced Prostate Cancer, Screening, Uncategorized|0 Comments

CDC May Lose Entire Prostate Cancer Funding

The national men’s cancer survivor support and advocacy nonprofit organization, Malecare, protests against the proposed elimination of funding for prostate cancer at the Centers for Disease Control and Prevention. Prostate cancer is one of the most common cancers in America. Almost 30,000 American men die from prostate cancer every year.  And, African American men die [...]

By |2015-02-05T12:00:11-05:00February 5th, 2015|Advanced Prostate Cancer, Advocacy|1 Comment

Oral Drug Parity – What Is It and Do I Have It?

Cancer survivors have many additional problems in their life. I guess the most significant problem is that we have a life threatening illness. So, why are we forced to have to worry if our medications will be paid for or if we are able to afford to pay for them? When we are fighting for [...]

*Smoking Doubles the Chance That Men with Prostate Cancer Will Die From the Cancer

In a new study it was shown that smoking doubles the chances that a prostate cancer survivor will have the cancer spread and that he would die from the cancer. Study co-author Dr. Michael Zelefsky, Vice Chair of Clinical Research in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center said, "Basically we [...]

Radiologic Progression Free Survival Might Predict Treatment Response and Survival

In a recent publication it was suggested that radiographic progression-free survival (rPFS) in men with metastatic castration-resistant prostate cancer (mCRPC) was highly consistent and highly associated with overall survival. This reproducible quantitative find could have implications for the interim measurement of treatment response in future studies, according to Dr. Michael J. Morris of Memorial Sloan [...]

Radiation Plus Hormone Therapy Prolongs Survival for Older Men with Locally Advanced Prostate Cancer *

It was recently discovered that if hormone therapy (ADT) is added to radiation cancer deaths are lowered by nearly 50 % in men with locally advanced prostate cancer aged 76 to 85 compared to men who only received hormone therapy. Prior studies have shown that 40% of men with aggressive prostate cancers are treated with [...]

Go to Top